Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.